OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
February 01, 2020
CDMOs must consider challenges associated with the complexity of contract pharmaceutical manufacturing when approaching digitalization projects.
As cell and gene therapies become more prominent, industry is seeking the expertise and capabilities of outsourcing partners to ensure success.
The need for manufacturing speed inspires contract manufacturers to explore advanced processing technologies.
CDMOs and CMOs will continue to invest in biopharmaceutical services and facilities as the bio/pharmaceutical industry looks to biosimilars and personalized medicine.
January 27, 2020
Drug development contract services company PPD announces initial public offering.
January 22, 2020
FDA revised the guidance after industry feedback and to clarify CGMP requirements for outsourcing facility operations.
January 16, 2020
Karen Flynn rejoins Catalent as president of biologics operations; regional presidents named for US and Europe.
January 15, 2020
Catalent’s FlexDirect service offers sponsors multiple delivery options from a single inventory.
January 09, 2020
Phillips-Medisize has announced that it is expanding its current Global Innovation and Development (GID) site in Struer, Denmark, to include a dedicated manufacturing development and clinical build unit.
January 08, 2020
Catalent completes purchase of biologics fill-finish and oral solid dose facility in Anagni, Italy